Ludwig Link

Bridging the parallel worlds of multiplex imaging and H&E microscopy

Sandro Santagata, Ludwig Cancer Research Harvard
Sandro Santagata
Peter Sorger, Ludwig Cancer Research Harvard
Peter Sorger
Jia-Ren Lin, Ludwig Cancer Research Harvard
Jia-Ren Lin
Yu-An Chen, Ludwig Cancer Research Harvard
Yu-An Chen

Researchers led by Ludwig Harvard’s Sandro Santagata, Peter Sorger, Jia-Ren Lin and Yu-An Chen described in a June Nature Cancer paper a platform technology that enables integration of the methods used in surgical pathology—the examination of hematoxylin and eosin (H&E) stained slides—with emerging research methods in multiplexed tissue imaging for visualization of multiple molecular markers in individual cells. The new platform, Orion, allowed both human experts and artificial intelligence algorithms to identify cellular and molecular features that predict progression-free survival of colorectal cancer (CRC) patients. Analyzing cancer specimens from 40 CRC patients, the researchers sifted through some 15,000 combinations of biomarkers to identify those most tightly linked to patient prognosis. They then applied them to samples from an additional cohort of CRC patients whose outcomes were known. Their biomarkers accurately predicted—just a one in 20 chance of being wrong—the likelihood of poor prognosis. The approach revealed interesting relationships between the molecular markers, cell morphology and tumor topography. One such finding indicated that inflammation—or immune activity—at the rim of the tumor is of pathological significance, while another revealed the molecular basis of a tissue morphology associated with a likelihood of metastasis.

High-plex immunofluorescence imaging and traditional histology of the same tissue section for discovering image-based biomarkers
Nature Cancer, 2023 June 22

 Back to November 2023 Ludwig Link

You are now leaving Ludwig Cancer Research's website and are going to a website that is not operated by the association. We are not responsible for the content or availability of linked sites. Do you wish to continue?